Author Guidelines

Jurnal Farmasi Sains dan Komunitas (Journal of Pharmaceutical Sciences and Community) firstly published in 2003, is a peer-reviewed, open access journal that publishes research articles, review articles, as well as short communication in various pharmaceutical fields, including Pharmaceutical Technology and Pharmaceutics, Pharmaceutical Analysis, Medicinal Chemistry, Pharmacology and Toxicology, Pharmaceutical Biology, Community Pharmacy, and Clinical Pharmacy.

Jurnal Farmasi Sains dan Komunitas accepts research articles, review articles, and short communication in English. Jurnal Farmasi Sains dan Komunitas is managed and published in Yogyakarta by Faculty of Pharmacy, Sanata Dharma University Yogyakarta, for twice a year (in May and November).

ARTICLE PREPARATION

Jurnal Farmasi Sains dan Komunitas (Journal of Pharmaceutical Sciences and Community) welcomes full research articles, review articles, and short communications. Full research articles - original   research   articles   which   have   not   been published previously should in general about 3000-5000 words (12 printed pages) including figures and tables (with maximum 6 figures or tables). Review articles – the review should not exceed 5000 words including figures and tables (with maximum of 6 figures or tables). Short communications - short communications should not exceed 2000 words (4 printed pages) with maximum 3 figures or tables.

Article should be prepared using common word processor software (e.g. Microsoft-Word®), prepared in English language, type single column in Cambria font with the size of 10, space of 1.0, page size of A4, left and top margins of 3 cm, right and bottom margin of 2.5 cm. To avoid unnecessary errors the authors are strongly advised to use the "spell-check" and "grammar-check" functions of the word processor.

Template file of the article could be downloaded here.

MANUSCRIPT STYLE

To be published in Jurnal Farmasi Sains dan Komunitas (Journal of Pharmaceutical Sciences and Community), the manuscripts should be divided into the following sections:

• Title Page – This section contains manuscript title with maximum of 18 words and should be written in English using title case style, authors’ names (without academic title) and affiliation (including address, postal code, country, email, and contact). Different author affiliations should be marked with superscript numbering 1, 2, 3, etc. The corresponding author should be marked with the superscript asterisk “*”.
• Abstract - The abstract should state briefly the aim of the research, method used, main results, and major conclusions. Abstract should be written in one paragraph with maximum of 200 words in English. Abstract should be accurate, brief, clear, specific, and avoided from non-standard or uncommon abbreviations.
• Keywords – Abstract should be accompanied with 3-5 keywords, alphabetically ordered, separated using semicolons, and prepared using the same language as abstract. Keywords are the labels of the manuscript and critical for indexing purpose.
• Introduction – In this section authors should provide an adequate background and a brief statement of previous relevant study. Introduction section should be avoided from a detailed literature survey or a summary of the results.
• Methods – This section provides information of materials, instrumentations, and methods used in order to allow the work to be reproduced by the readers. Methods already published should be indicated by a reference: only relevant modifications should be described. For the chemicals, authors should provide details of brand and purity, for example: ammonia 25% (Merck Millipore).
• Results and Discussion - The results should be clear and concise of summarizing (scientific) findings rather than providing data in great detail. The discussion should explore the significance of the results of the work. Avoid extensive citations and discussion of published literature.
• Conclusion - The main conclusions of the study should be presented in a short Conclusions section. Conclusions should answer the objectives of research. In this section, authors could also suggest future experiments and/or point out those that are underway.
• Acknowledgement - Advisors, financial supporters, or other supporters i.e. proofreaders, typists, and suppliers who have assisted authors in the research can be listed in this section.
• Author Contributions - For manuscripts written by multiple authors, a clear description of each author’s individual contributions must be included. Please use the following standardized format: “Conceptualization, X.X. and Y.Y.; methodology, X.X.; software, X.X.; validation, X.X., Y.Y. and Z.Z.; formal analysis, X.X.; investigation, X.X.; resources, X.X.; data curation, X.X.; writing—original draft preparation, X.X.; writing—review and editing, X.X.; visualization, X.X.; supervision, X.X.; project administration, X.X.; funding acquisition, Y.Y. All authors have read and agreed to the published version of the manuscript.” Each contributor should be clearly identified according to their respective roles. Authorship must be restricted to those who have made significant contributions to the work. Prior to submission, all authors are required to approve the contribution statement.
• Declaration Of Artificial Intelligence - Manuscripts submitted to J. Pharm. Sci. Community are subject to AI writing detection screening. The maximum permissible AI Writing Detection Score for any submitted manuscript is 20%. Authors whose manuscripts show elevated AI scores but who declare use of grammar checkers or machine translation may be requested to: (a) provide the original draft prior to AI-assisted editing; (b) explain their writing and editing process in detail; or (c) undergo an editorial interview to verify authorship and understanding of the content.
  Any use of AI beyond basic spell-checking must be transparently declared in the submitted manuscript. The disclosure must include:
  1. The name, type, and version of the AI tool(s) used
  2. A brief description of how AI was used in the manuscript (e.g., grammar correction, translation, literature search)
  3. The specific prompts or instructions given to the AI tool, where relevant
  4. A statement confirming that all authors reviewed and take full responsibility for all AI-assisted content

  Example:
  “In the preparation of this manuscript, the authors used Grammarly (Version 1.0) to improve grammatical accuracy and sentence clarity. All AI-generated suggestions were reviewed, edited, and validated by the authors.”

• Conflict of Interest - If there are conflict of interest, it should be state clearly. Financial and personal relationships should be easily identifiable, leading to bias in work. The sources of funding for the work should be described explicitly with explanations of the roles of those sources, and the authors should state that the sources of support do not participate in specific roles. The authors should state that the authors have access to all the studies and that the sponsors have not interacted with the data or the work. Conversely, if the authors do not have a conflict of interest, they may find them expressly stately
• References - All publications cited in the text should be included as a list of references.

The references used should be up to date (maximum of 10 years) and dominated of journal articles (at least 80%). It is highly recommended to use the reference manager to organize the references such as Zotero, Mendeley, Endnote, etc. The reference style used can be found in https://s.usd.ac.id/jpsc-csl.  If you are a Mendeley user, you can install the journal's reference style by accessing https://csl.mendeley.com/styles/28740611/journal-of-pharmaceutical-sciences-and-community.

Book

Miller, J.N., Miller, J.C., Miller, R.D., 2018. Statistics and Chemometrics for Analytical Chemistry, Seventh Ed. ed. Pearson Education Limited, Harlow.

Book Chapters

Cournia, Z., Chipot, C., Roux, B., York, D.M., Sherman, W., 2021. Free Energy Methods in Drug Discovery-Introduction, in: Armacost, K.A., Thompson, D.C. (Eds.), Free Energy Methods in Drug Discovery: Current State and Future Directions. American Chemical Society.

Conference proceeding

Dina Christin Ayuning Putri, Merry Permatasari, Nico Ade Putra, Julius Andrye Lesmana, 2022. Formulasi Sediaan Masker Gel Peel-Off Ekstrak Mentimun Kombinasi Ekstrak Buah Lemon dengan Variasi Konsentrasi PVA dan HPMC, in: Florentinus Dika Octa Riswanto (Ed.), Prosiding Seminar Nasional Farmasi: “The Future of Pharmacy and Health Technology in Degenerative and Tropical Disease.” Faculty of Pharmacy, Universitas Sanata Dharma, Yogyakarta, pp. 1–9.

Journal Article

Riswanto, F.D.O., Adventra, N.D.D., Priyambodo, G.S., Kusraynaldi, T.M., Sembiring, A.Y.S.B., Larasati, T.N., Windarsih, A., Waskitha, S.S.W., Gani, M.R., Istyastono, E.P., 2025. A comprehensive study of ground-roasted coffee beans from Coffea liberica as dipeptidyl peptidase IV inhibitors. European Pharmaceutical Journal, 72(1), 1–12.

Guidelines

Arnett, D.K., Blumenthal, R.S., Albert, M.A., Buroker, A.B., Goldberger, Z.D., Hahn, E.J., Himmelfarb, C.D., Khera, A., Lloyd-Jones, D., McEvoy, J.W., Michos, E.D., Miedema, M.D., Muñoz, D., Smith, S.C., Virani, S.S., Williams, K.A., Yeboah, J., Ziaeian, B., 2019. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 140(11), e596–e646.

Online

Chay, C., 2025. Understanding ROC-AUC and Single-Factor AR: A Practical Guide to Classification Metrics [WWW Document]. Medium,. URL https://medium.com/@carelchay/understanding-roc-auc-and-single-factor-ar-a-practical-guide-to-classification-metrics-ca34ec2cbb1d (accessed 5.8.26).